Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |